|
|
| (51 tussenliggende versies worden niet weergegeven) |
| Regel 1: |
Regel 1: |
| - | In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd: | + | In onderstaande tabel staan per hoofdstuk/paragraaf verwijzingen naar andere richtlijnen vermeld:<br> |
| | | | |
| - | <html xmlns:v="urn:schemas-microsoft-com:vml"
| + | {| width="100%" border="1" align="left" cellspacing="1" cellpadding="1" |
| - | xmlns:o="urn:schemas-microsoft-com:office:office"
| + | |- |
| - | xmlns:w="urn:schemas-microsoft-com:office:word"
| + | | valign="top" align="left" | '''Pagina'''<br> |
| - | xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
| + | | width="45" valign="top" align="left" | '''Link naar andere richtlijn''' |
| - | xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=windows-1252"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 14"><meta name=Originator content="Microsoft Word 14"><link rel=File-List
| + | |- |
| - | href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/filelist.xml"><!--[if gte mso 9]><xml><o:DocumentProperties><o:Author>Mariska Tuut</o:Author><o:LastAuthor>Mariska Tuut</o:LastAuthor><o:Revision>1</o:Revision><o:TotalTime>24</o:TotalTime><o:Created>2011-12-09T13:52:00Z</o:Created><o:LastSaved>2011-12-09T14:16:00Z</o:LastSaved><o:Pages>3</o:Pages><o:Words>2123</o:Words><o:Characters>11680</o:Characters><o:Lines>97</o:Lines><o:Paragraphs>27</o:Paragraphs><o:CharactersWithSpaces>13776</o:CharactersWithSpaces><o:Version>14.00</o:Version></o:DocumentProperties><o:OfficeDocumentSettings><o:AllowPNG/></o:OfficeDocumentSettings></xml><![endif]--><link rel=themeData
| + | | valign="top" align="left" | [[Inhoud|'''Inhoud''']] |
| - | href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/themedata.thmx"><link rel=colorSchemeMapping
| + | | width="45" valign="top" align="left" | SOA richtlijn<br>PrEP richtlijn |
| - | href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/colorschememapping.xml"><!--[if gte mso 9]><xml><w:WordDocument><w:SpellingState>Clean</w:SpellingState><w:GrammarState>Clean</w:GrammarState><w:TrackMoves>false</w:TrackMoves><w:TrackFormatting/><w:HyphenationZone>21</w:HyphenationZone><w:PunctuationKerning/><w:ValidateAgainstSchemas/><w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid><w:IgnoreMixedContent>false</w:IgnoreMixedContent><w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText><w:DoNotPromoteQF/><w:LidThemeOther>NL</w:LidThemeOther><w:LidThemeAsian>X-NONE</w:LidThemeAsian><w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript><w:Compatibility><w:BreakWrappedTables/><w:SnapToGridInCell/><w:WrapTextWithPunct/><w:UseAsianBreakRules/><w:DontGrowAutofit/><w:SplitPgBreakAndParaMark/><w:EnableOpenTypeKerning/><w:DontFlipMirrorIndents/><w:OverrideTableStyleHps/></w:Compatibility><m:mathPr><m:mathFont m:val="Cambria Math"/><m:brkBin m:val="before"/><m:brkBinSub m:val="--"/><m:smallFrac m:val="off"/><m:dispDef/><m:lMargin m:val="0"/><m:rMargin m:val="0"/><m:defJc m:val="centerGroup"/><m:wrapIndent m:val="1440"/><m:intLim m:val="subSup"/><m:naryLim m:val="undOvr"/></m:mathPr></w:WordDocument></xml><![endif]--><!--[if gte mso 9]><xml><w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
| + | |- |
| - | DefSemiHidden="true" DefQFormat="false" DefPriority="99"
| + | | valign="top" align="left" | '''[[Hoofdstuk 2. Therapie bij volwassenen]]<br>''' |
| - | LatentStyleCount="267"><w:LsdException Locked="false" Priority="0" SemiHidden="false"
| + | | width="45" valign="top" align="left" | <br> |
| - | UnhideWhenUsed="false" QFormat="true" Name="Normal"/><w:LsdException Locked="false" Priority="9" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" QFormat="true" Name="heading 1"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/><w:LsdException Locked="false" Priority="39" Name="toc 1"/><w:LsdException Locked="false" Priority="39" Name="toc 2"/><w:LsdException Locked="false" Priority="39" Name="toc 3"/><w:LsdException Locked="false" Priority="39" Name="toc 4"/><w:LsdException Locked="false" Priority="39" Name="toc 5"/><w:LsdException Locked="false" Priority="39" Name="toc 6"/><w:LsdException Locked="false" Priority="39" Name="toc 7"/><w:LsdException Locked="false" Priority="39" Name="toc 8"/><w:LsdException Locked="false" Priority="39" Name="toc 9"/><w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/><w:LsdException Locked="false" Priority="10" SemiHidden="false"
| + | | valign="top" align="left" | [[2.1. Wanneer beginnen?]] <br> |
| - | UnhideWhenUsed="false" QFormat="true" Name="Title"/><w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/><w:LsdException Locked="false" Priority="11" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/><w:LsdException Locked="false" Priority="22" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" QFormat="true" Name="Strong"/><w:LsdException Locked="false" Priority="20" SemiHidden="false"
| + | | valign="top" align="left" | [[2.2. Keuze van antiretrovirale therapie bij naïeve volwassenen met hiv|2.2. Keuze van anti-retrovirale therapie bij naïeve volwassenen met hiv]]<br> |
| - | UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/><w:LsdException Locked="false" Priority="59" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Table Grid"/><w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/><w:LsdException Locked="false" Priority="1" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | | valign="top" align="left" | [[2.3. Tijdelijk onderbreken van antiretrovirale therapie|2.3. Tijdelijk onderbreken van anti-retrovirale therapie]]<br> |
| - | UnhideWhenUsed="false" Name="Light Shading"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Light List"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light Grid"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | | valign="top" align="left" | [[2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde mensen met hiv|2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde mensen met hiv]]<br> |
| - | UnhideWhenUsed="false" Name="Medium Shading 1"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Medium Shading 2"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium List 1"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 3. Behandeling van hiv-1 infectie bij kinderen|Hoofdstuk 3. Behandeling van hiv-1 infectie bij kinderen]]''' |
| - | UnhideWhenUsed="false" Name="Medium List 2"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS<br>Kinderformularium |
| - | UnhideWhenUsed="false" Name="Medium Grid 1"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 2"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 4. Monitoring]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium Grid 3"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Dark List"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful Shading"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | | valign="top" align="left" | [[4.2. Spiegelbepaling]]<br> |
| - | UnhideWhenUsed="false" Name="Colorful List"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | | width="45" valign="top" align="left" | |
| - | UnhideWhenUsed="false" Name="Colorful Grid"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | DHHS<br>EACS<br>TDM-protocollen |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 1"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Light List Accent 1"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 1"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | | valign="top" align="left" | [[4.3. Resistentiebepalingen]]<br> |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/><w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/><w:LsdException Locked="false" Priority="34" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 5. Diagnostiek en behandeling primaire hiv-infectie|Hoofdstuk 5. Diagnostiek en behandeling primaire hiv-infectie]]<br>''' |
| - | UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/><w:LsdException Locked="false" Priority="29" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" QFormat="true" Name="Quote"/><w:LsdException Locked="false" Priority="30" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale periode]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS <br> Landelijk hiv expositie protocol neonaten |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 8. HIV-2 bij volwassenen: Behandeling en monitoring]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS |
| - | UnhideWhenUsed="false" Name="Dark List Accent 1"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 9. Bijzondere omstandigheden]]''' |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 1"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | | width="45" valign="top" align="left" | |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 2"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | | valign="top" align="left" | [[9.5. Adviezen m.b.t. gebruik anti-hiv middelen door de sonde]] |
| - | UnhideWhenUsed="false" Name="Light List Accent 2"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | | width="45" valign="top" align="left" | EACS |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 2"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | | valign="top" align="left" | [[9.6. Doseringen bij gestoorde leverfunctie]] |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | | width="45" valign="top" align="left" | EACS |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | | valign="top" align="left" | [[9.7. Doseringen bij gestoorde nierfunctie]] |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | | width="45" valign="top" align="left" | EACS |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij mensen met hiv-1|Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij mensen met hiv-1]]<br>''' |
| - | UnhideWhenUsed="false" Name="Dark List Accent 2"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | | width="45" valign="top" align="left" | <br> |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 2"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | | valign="top" align="left" | [[10.1. Hepatitis B]]<br> |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | | width="45" valign="top" align="left" | HBV richtsnoer<br>DHHS<br>EACS |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 3"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light List Accent 3"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | | valign="top" align="left" | [[10.2. Hepatitis C|10.2. Hepatitis C]] |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 3"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | | width="45" valign="top" align="left" | HCV richtsnoer<br> DHHS<br>EACS |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | | valign="top" align="left" | [[10.3. HCC surveillance|10.3. HCC surveillance]] |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | | width="45" valign="top" align="left" | HBV richtsnoer |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 11. Behandeling van tuberculose bij mensen met een hiv-infectie|Hoofdstuk 11. Behandeling van tuberculose bij mensen met een hiv-infectie]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | | width="45" valign="top" align="left" | KNCV |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Dark List Accent 3"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 12. Comorbiditeit en bijwerkingen]]<br>''' |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | | width="45" valign="top" align="left" | EACS<br> |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 3"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 13. Screening van mensen met hiv op anogenitale maligniteiten|Hoofdstuk 13. Screening van mensen met hiv op anogenitale maligniteiten]] <br>''' |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 4"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS<br> CIN cervicale intra-epitheliale neoplasie |
| - | UnhideWhenUsed="false" Name="Light List Accent 4"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 4"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 14. Interacties]]''' |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | | width="45" valign="top" align="left" | EACS |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | | valign="top" align="left" | [[Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie|'''Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie''']] |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | | width="45" valign="top" align="left" | DHHS<br>Nationale Antibioticaboekje<br>SWAB richtlijnen |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 16. Transmissiemanagement]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | | width="45" valign="top" align="left" | <br> |
| - | UnhideWhenUsed="false" Name="Dark List Accent 4"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | | valign="top" align="left" | [[16.1. Prikaccidenten]]<br> |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 4"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | | width="45" valign="top" align="left" | LCI |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 5"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | | valign="top" align="left" | [[16.2. Seksaccidenten]]<br> |
| - | UnhideWhenUsed="false" Name="Light List Accent 5"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | | width="45" valign="top" align="left" | LCI/RIVM |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 5"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | | valign="top" align="left" | '''[[Hoofdstuk 17. Vaccinatiebeleid]]<br>''' |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | | width="45" valign="top" align="left" | <br> |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | | valign="top" align="left" | [[17.2. Vaccinatie tegen influenza]] <br> |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | | width="45" valign="top" align="left" | RIVM<br>NHG |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | | valign="top" align="left" | [[17.4. Vaccinaties tegen Hepatitis A en B]]<br> |
| - | UnhideWhenUsed="false" Name="Dark List Accent 5"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | | width="45" valign="top" align="left" | RIVM |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 5"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | | valign="top" align="left" | [https://richtlijnhiv.nvhb.nl/index.php/Addendum:%C2%A0SOA-richtlijn '''Addendum:''' SOA-richtlijn] |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
| + | | width="45" valign="top" align="left" | SOA richtlijn |
| - | UnhideWhenUsed="false" Name="Light Shading Accent 6"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
| + | |- |
| - | UnhideWhenUsed="false" Name="Light List Accent 6"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
| + | | valign="top" align="left" | [http://richtlijnhiv.nvhb.nl/images/2/22/PrEP-richtlijn-Nederland-8-september-2016-met-logos.pdf '''Addendum:''' Pre-exposure profylaxe (PrEP) richtlijn] |
| - | UnhideWhenUsed="false" Name="Light Grid Accent 6"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
| + | | width="45" valign="top" align="left" | PrEP-richtlijn |
| - | UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
| + | |} |
| - | UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Dark List Accent 6"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Colorful List Accent 6"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/><w:LsdException Locked="false" Priority="19" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/><w:LsdException Locked="false" Priority="21" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/><w:LsdException Locked="false" Priority="31" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/><w:LsdException Locked="false" Priority="32" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/><w:LsdException Locked="false" Priority="33" SemiHidden="false"
| + | |
| - | UnhideWhenUsed="false" QFormat="true" Name="Book Title"/><w:LsdException Locked="false" Priority="37" Name="Bibliography"/><w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/></w:LatentStyles></xml><![endif]--><style><!--
| + | |
| - | /* Font Definitions */
| + | |
| - | @font-face
| + | |
| - | {font-family:"Cambria Math";
| + | |
| - | panose-1:2 4 5 3 5 4 6 3 2 4;
| + | |
| - | mso-font-charset:1;
| + | |
| - | mso-generic-font-family:roman;
| + | |
| - | mso-font-format:other;
| + | |
| - | mso-font-pitch:variable;
| + | |
| - | mso-font-signature:0 0 0 0 0 0;}
| + | |
| - | @font-face
| + | |
| - | {font-family:Calibri;
| + | |
| - | panose-1:2 15 5 2 2 2 4 3 2 4;
| + | |
| - | mso-font-charset:0;
| + | |
| - | mso-generic-font-family:swiss;
| + | |
| - | mso-font-pitch:variable;
| + | |
| - | mso-font-signature:-520092929 1073786111 9 0 415 0;}
| + | |
| - | /* Style Definitions */
| + | |
| - | p.MsoNormal, li.MsoNormal, div.MsoNormal
| + | |
| - | {mso-style-unhide:no;
| + | |
| - | mso-style-qformat:yes;
| + | |
| - | mso-style-parent:"";
| + | |
| - | margin-top:0cm;
| + | |
| - | margin-right:0cm;
| + | |
| - | margin-bottom:10.0pt;
| + | |
| - | margin-left:0cm;
| + | |
| - | line-height:115%;
| + | |
| - | mso-pagination:widow-orphan;
| + | |
| - | font-size:11.0pt;
| + | |
| - | font-family:"Calibri","sans-serif";
| + | |
| - | mso-ascii-font-family:Calibri;
| + | |
| - | mso-ascii-theme-font:minor-latin;
| + | |
| - | mso-fareast-font-family:Calibri;
| + | |
| - | mso-fareast-theme-font:minor-latin;
| + | |
| - | mso-hansi-font-family:Calibri;
| + | |
| - | mso-hansi-theme-font:minor-latin;
| + | |
| - | mso-bidi-font-family:"Times New Roman";
| + | |
| - | mso-bidi-theme-font:minor-bidi;
| + | |
| - | mso-fareast-language:EN-US;}
| + | |
| - | a:link, span.MsoHyperlink
| + | |
| - | {mso-style-noshow:yes;
| + | |
| - | mso-style-priority:99;
| + | |
| - | color:blue;
| + | |
| - | text-decoration:underline;
| + | |
| - | text-underline:single;}
| + | |
| - | a:visited, span.MsoHyperlinkFollowed
| + | |
| - | {mso-style-noshow:yes;
| + | |
| - | mso-style-priority:99;
| + | |
| - | color:purple;
| + | |
| - | mso-themecolor:followedhyperlink;
| + | |
| - | text-decoration:underline;
| + | |
| - | text-underline:single;}
| + | |
| - | span.SpellE
| + | |
| - | {mso-style-name:"";
| + | |
| - | mso-spl-e:yes;}
| + | |
| - | span.GramE
| + | |
| - | {mso-style-name:"";
| + | |
| - | mso-gram-e:yes;}
| + | |
| - | .MsoChpDefault
| + | |
| - | {mso-style-type:export-only;
| + | |
| - | mso-default-props:yes;
| + | |
| - | mso-ascii-font-family:Calibri;
| + | |
| - | mso-ascii-theme-font:minor-latin;
| + | |
| - | mso-fareast-font-family:Calibri;
| + | |
| - | mso-fareast-theme-font:minor-latin;
| + | |
| - | mso-hansi-font-family:Calibri;
| + | |
| - | mso-hansi-theme-font:minor-latin;
| + | |
| - | mso-bidi-font-family:"Times New Roman";
| + | |
| - | mso-bidi-theme-font:minor-bidi;
| + | |
| - | mso-fareast-language:EN-US;}
| + | |
| - | .MsoPapDefault
| + | |
| - | {mso-style-type:export-only;
| + | |
| - | margin-bottom:10.0pt;
| + | |
| - | line-height:115%;}
| + | |
| - | @page WordSection1
| + | |
| - | {size:595.3pt 841.9pt;
| + | |
| - | margin:70.85pt 70.85pt 70.85pt 70.85pt;
| + | |
| - | mso-header-margin:35.4pt;
| + | |
| - | mso-footer-margin:35.4pt;
| + | |
| - | mso-paper-source:0;}
| + | |
| - | div.WordSection1
| + | |
| - | {page:WordSection1;}
| + | |
| - | --></style><!--[if gte mso 10]><style>
| + | |
| - | /* Style Definitions */
| + | |
| - | table.MsoNormalTable
| + | |
| - | {mso-style-name:Standaardtabel;
| + | |
| - | mso-tstyle-rowband-size:0;
| + | |
| - | mso-tstyle-colband-size:0;
| + | |
| - | mso-style-noshow:yes;
| + | |
| - | mso-style-priority:99;
| + | |
| - | mso-style-parent:"";
| + | |
| - | mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
| + | |
| - | mso-para-margin-top:0cm;
| + | |
| - | mso-para-margin-right:0cm;
| + | |
| - | mso-para-margin-bottom:10.0pt;
| + | |
| - | mso-para-margin-left:0cm;
| + | |
| - | line-height:115%;
| + | |
| - | mso-pagination:widow-orphan;
| + | |
| - | font-size:11.0pt;
| + | |
| - | font-family:"Calibri","sans-serif";
| + | |
| - | mso-ascii-font-family:Calibri;
| + | |
| - | mso-ascii-theme-font:minor-latin;
| + | |
| - | mso-hansi-font-family:Calibri;
| + | |
| - | mso-hansi-theme-font:minor-latin;
| + | |
| - | mso-bidi-font-family:"Times New Roman";
| + | |
| - | mso-bidi-theme-font:minor-bidi;
| + | |
| - | mso-fareast-language:EN-US;}
| + | |
| - | table.MsoTableGrid
| + | |
| - | {mso-style-name:Tabelraster;
| + | |
| - | mso-tstyle-rowband-size:0;
| + | |
| - | mso-tstyle-colband-size:0;
| + | |
| - | mso-style-priority:59;
| + | |
| - | mso-style-unhide:no;
| + | |
| - | border:solid windowtext 1.0pt;
| + | |
| - | mso-border-alt:solid windowtext .5pt;
| + | |
| - | mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
| + | |
| - | mso-border-insideh:.5pt solid windowtext;
| + | |
| - | mso-border-insidev:.5pt solid windowtext;
| + | |
| - | mso-para-margin:0cm;
| + | |
| - | mso-para-margin-bottom:.0001pt;
| + | |
| - | mso-pagination:widow-orphan;
| + | |
| - | font-size:11.0pt;
| + | |
| - | font-family:"Calibri","sans-serif";
| + | |
| - | mso-ascii-font-family:Calibri;
| + | |
| - | mso-ascii-theme-font:minor-latin;
| + | |
| - | mso-hansi-font-family:Calibri;
| + | |
| - | mso-hansi-theme-font:minor-latin;
| + | |
| - | mso-bidi-font-family:"Times New Roman";
| + | |
| - | mso-bidi-theme-font:minor-bidi;
| + | |
| - | mso-fareast-language:EN-US;}
| + | |
| - | </style><![endif]--><!--[if gte mso 9]><xml><o:shapedefaults v:ext="edit" spidmax="1026"/></xml><![endif]--><!--[if gte mso 9]><xml><o:shapelayout v:ext="edit"><o:idmap v:ext="edit" data="1"/></o:shapelayout></xml><![endif]--></head><body lang=NL link=blue vlink=purple style='tab-interval:35.4pt'><div class=WordSection1>
| + | |
| - | {| class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt' style='mso-yfti-irow:0;mso-yfti-firstrow:yes'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b>Pagina<o:p></o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b>Verwijzing naar andere richtlijnen<o:p></o:p></b></p>
| + | |
| - | |- style='mso-yfti-irow:1'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Richtlijn%20HIV">Hoofdpagina
| + | |
| - | (=inhoudsopgave)</a><o:p></o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:2'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:3'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%201.%20Achtergrondinformatie%20bij%20de%20ontwikkeling%20en%20herziening%20van%20deze%20richtlijn%20en%20inleiding">Hoofdstuk
| + | |
| - | 1. Achtergrondinformatie bij de ontwikkeling en herziening van deze richtlijn
| + | |
| - | en inleiding</a><o:p></o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'>NVHB Richtlijn 2007<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:4'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Procedure%20herziening">Procedure
| + | |
| - | herziening</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'>NVHB Richtlijn 2007</p>
| + | |
| - | |- style='mso-yfti-irow:5'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Samenstelling%20kernwerkgroep">Samenstelling
| + | |
| - | kernwerkgroep</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:6'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Overzicht%20belangen%20werkgroepleden">Overzicht
| + | |
| - | belangen werkgroepleden</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:7'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Definities">Definities</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:8'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'>Geschiedenis per pagina van deze richtlijn (= huidige pagina)</p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:9' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:10'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%202.%20Therapie%20bij%20volwassenen">Hoofdstuk
| + | |
| - | 2. Therapie bij volwassenen</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:11'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.1.%20Wanneer%20beginnen?">2.1.
| + | |
| - | Wanneer beginnen?</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:12' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20wanneer%20starten">Onderbouwing
| + | |
| - | wanneer starten</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
| + | |
| - | |- style='mso-yfti-irow:13'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.1">Literatuur
| + | |
| - | 2.1</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:14' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.2.%20Keuze%20van%20antiretrovirale%20therapie%20bij%20na%C3%AFeve%20volwassen%20pati%C3%ABnten">2.2.
| + | |
| - | Keuze van antiretrovirale therapie bij naïeve volwassen patiënten</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
| + | |
| - | |- style='mso-yfti-irow:15'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.2">Literatuur
| + | |
| - | 2.2</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:16' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.3.%20Tijdelijk%20onderbreken%20van%20HAART">2.3.
| + | |
| - | Tijdelijk onderbreken van HAART</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
| + | |
| - | |- style='mso-yfti-irow:17'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/T%C2%BD%20van%20antiretrovirale%20middelen">T½
| + | |
| - | van antiretrovirale middelen</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:18' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.4.%20Richtlijn%20anti-retrovirale%20therapie%20bij%20voorbehandelde%20pati%C3%ABnten">2.4.
| + | |
| - | Richtlijn <span class=SpellE>anti-retrovirale</span> therapie bij <span | + | |
| - | class=SpellE>voorbehandelde</span> patiënten</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
| + | |
| - | |- style='mso-yfti-irow:19' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:20'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%203.%20Behandeling%20van%20HIV-1%20infectie%20bij%20kinderen">Hoofdstuk
| + | |
| - | 3. Behandeling van HIV-1 infectie bij kinderen</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span style='mso-bidi-font-weight:bold'>Penta</span></span><span
| + | |
| - | style='mso-bidi-font-weight:bold'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
| + | |
| - | bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
| + | |
| - | NIH<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:21'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:22' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%204.%20Monitoring">Hoofdstuk
| + | |
| - | 4. Monitoring</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:23'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.1.%20Controles%20HIV-pati%C3%ABnten%20%28polikliniek%29">4.1.
| + | |
| - | Controles HIV-patiënten (polikliniek)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:24' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20eerste%20consult%20bij%20HIV-seropositieve%20pati%C3%ABnt%20%28polikliniek%29">Bij
| + | |
| - | eerste consult bij <span class=SpellE>HIV-seropositieve</span> patiënt
| + | |
| - | (polikliniek)</a><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20instellen%20op%20antiretrovirale%20therapie%20%28polikliniek%29"
| + | |
| - | _fcknotitle=true
| + | |
| - | _fcksavedurl="Bij instellen op antiretrovirale therapie (polikliniek)">Bij
| + | |
| - | instellen op antiretrovirale therapie (polikliniek)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:25' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Eerste%20controle%20na%20instellen%20op%20anti-retrovirale%20therapie%204-6%20weken%20na%20start%20%28polikliniek%29">Eerste
| + | |
| - | controle na instellen op <span class=SpellE>anti-retrovirale</span> therapie
| + | |
| - | 4-6 weken na start (polikliniek)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:26'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20op%20antiretrovirale%20therapie%20%28polikliniek%29">Controle
| + | |
| - | van patiënten op antiretrovirale therapie (polikliniek)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:27' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20zonder%20antiretrovirale%20therapie%20%28polikliniek%29">Controle
| + | |
| - | van patiënten zonder antiretrovirale therapie (polikliniek)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:28'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.2.%20Spiegelbepaling">4.2.
| + | |
| - | Spiegelbepaling</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:29'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.3.%20Resistentiebepalingen">4.3.
| + | |
| - | Resistentiebepalingen</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:30' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:31'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%205.%20Diagnostiek%20en%20behandeling%20primaire%20HIV-infectie">Hoofdstuk
| + | |
| - | 5. Diagnostiek en behandeling primaire <span class=SpellE>HIV-infectie</span></a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
| + | |
| - | bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
| + | |
| - | NIH<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:32'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:33'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%206.%20Therapietrouw%20bevorderende%20maatregelen">Hoofdstuk
| + | |
| - | 6. Therapietrouw bevorderende maatregelen</a><o:p></o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:34'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.1.%20Therapietrouw%20be%C3%AFnvloedende%20factoren">6.1.
| + | |
| - | Therapietrouw beïnvloedende factoren</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:35' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.1">Literatuur
| + | |
| - | 6.1</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:36'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.2.%20Therapietrouw%20bevorderende%20interventies">6.2.
| + | |
| - | Therapietrouw bevorderende interventies</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:37'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20therapietrouw%20bevorderende%20interventies">Onderbouwing
| + | |
| - | therapietrouw bevorderende interventies</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:38'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.2">Literatuur
| + | |
| - | 6.2</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:39'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:40'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%207.%20Preventie%20van%20moeder-kind%20overdracht:%20zwangerschap,%20bevalling%20en%20neonatale%20periode">Hoofdstuk
| + | |
| - | 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale | + | |
| - | periode</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
| + | |
| - | bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
| + | |
| - | NIH Perinatal<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'>NVHB Richtlijn 2007<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:41'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%207">Literatuur
| + | |
| - | 7</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:42' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:43'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%208.%20HIV-2%20bij%20volwassenen:%20Behandeling%20en%20monitoring">Hoofdstuk
| + | |
| - | 8. HIV-2 bij volwassenen: Behandeling en monitoring</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
| + | |
| - | bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
| + | |
| - | NIH<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:44'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%208">Literatuur
| + | |
| - | 8</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:45' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:46'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%209.%20Bijzondere%20omstandigheden">Hoofdstuk
| + | |
| - | 9. Bijzondere omstandigheden</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:47' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.1.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20na%20braken">9.1.
| + | |
| - | Adviezen m.b.t. inname van anti-HIV middelen na braken</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:48' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.2.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20bij%20vergeten%20van%20slikmoment">9.2.
| + | |
| - | Adviezen m.b.t. inname van anti-HIV middelen bij vergeten van slikmoment</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:49'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.3.%20Marge%20tussen%20twee%20innames">9.3.
| + | |
| - | Marge tussen twee innames</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:50' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.4.%20Inname%20medicatie%20bij%20overschrijden%20tijdzones">9.4.
| + | |
| - | Inname medicatie bij overschrijden tijdzones</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:51'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.5.%20Adviezen%20m.b.t.%20gebruik%20anti-HIV%20middelen%20door%20de%20sonde">9.5.
| + | |
| - | Adviezen m.b.t. gebruik anti-HIV middelen door de sonde</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:52' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.6.%20Doseringen%20bij%20gestoorde%20lever-%20en%20nierfunctie">9.6.
| + | |
| - | Doseringen bij gestoorde lever- en nierfunctie</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:53' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:54'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2010.%20Behandeling%20van%20hepatitis%20B/C-virus%20co%C3%AFnfectie%20bij%20HIV-1%20positieve%20pati%C3%ABnten">Hoofdstuk
| + | |
| - | 10. Behandeling van hepatitis B/C-virus <span class=SpellE>coïnfectie</span> | + | |
| - | bij HIV-1 positieve patiënten</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:55' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.1.%20Hepatitis%20B"><span
| + | |
| - | lang=EN-US style='mso-ansi-language:EN-US'>10.1. Hepatitis B</span></a><span
| + | |
| - | lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>EACS</p>
| + | |
| - | |- style='mso-yfti-irow:56' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.2.%20Hepatitis%20C%C2%A0%28acuut%29"><span
| + | |
| - | lang=EN-US style='mso-ansi-language:EN-US'>10.2. Hepatitis C (<span
| + | |
| - | class=SpellE>acuut</span>)</span></a><span lang=EN-US style='mso-ansi-language:
| + | |
| - | EN-US'><o:p></o:p></span></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>NL aanbevelingen</p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'>NEAT</p>
| + | |
| - | |- style='mso-yfti-irow:57'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Levels%20of%20evidence"><span
| + | |
| - | lang=EN-US style='mso-ansi-language:EN-US'>Levels of evidence</span></a><span
| + | |
| - | lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:58' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2010.2">Literatuur
| + | |
| - | 10.2</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:59'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.3.%20Hepatitis%20C%C2%A0%28chronisch%29">10.3.
| + | |
| - | Hepatitis C (chronisch)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>EACS</p>
| + | |
| - | |- style='mso-yfti-irow:60' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:61'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2011.%20Behandeling%20van%20tuberculose%20bij%20pati%C3%ABnten%20met%20een%20HIV-infectie">Hoofdstuk
| + | |
| - | 11. Behandeling van tuberculose bij patiënten met een HIV-<span class=SpellE>infectie</span></a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'>CBO Tuberculose-HIV<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:62'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2011">Literatuur
| + | |
| - | 11</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:63' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:64'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2012.%20Comorbiditeit%20en%20bijwerkingen">Hoofdstuk
| + | |
| - | 12. Comorbiditeit en bijwerkingen</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'>EACS<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:65' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:66'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2013.%20Screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Hoofdstuk
| + | |
| - | 13. Screening van HIV-patiënten op anogenitale maligniteiten</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:67'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Onderbouwing
| + | |
| - | screening van HIV-patiënten op anogenitale maligniteiten</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:68'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2013">Literatuur
| + | |
| - | 13</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:69'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:70'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2014.%20Interacties">Hoofdstuk
| + | |
| - | 14. Interacties</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:71'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:72' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2015.%20Profylaxe%20en%20behandeling%20van%20opportunistische%20infectie">Hoofdstuk
| + | |
| - | 15. Profylaxe en behandeling van opportunistische infectie</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><span style='mso-bidi-font-weight:bold'>CDC<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span class=GramE><span style='mso-bidi-font-weight:bold'>Nationale</span></span><span
| + | |
| - | style='mso-bidi-font-weight:bold'> antibioticaboekje<o:p></o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:73'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:74' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>Hoofdstuk 16. Post Exposure Profylaxe na prikaccident en onveilig <span
| + | |
| - | class=SpellE>sexueel</span> contact</p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:75'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2016.%20Transmissiereductie%20%28PEP%29">Hoofdstuk
| + | |
| - | 16. <span class=GramE>Transmissiereductie</span> (PEP)</a><o:p></o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:76' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.1.%20Prikaccidenten">16.1.
| + | |
| - | Prikaccidenten</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>LCI</p>
| + | |
| - | |- style='mso-yfti-irow:77' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.2.%20Seksaccidenten">16.2.
| + | |
| - | Seksaccidenten</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>LCI/RIVM</p>
| + | |
| - | |- style='mso-yfti-irow:78' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:79'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2017.%20Vaccinatiebeleid">Hoofdstuk
| + | |
| - | 17. Vaccinatiebeleid</a><o:p></o:p></b></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:80'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.1.%20Vaccinaties%20bij%20HIV-ge%C3%AFnfecteerde%20kinderen">17.1.
| + | |
| - | Vaccinaties bij <span class=SpellE>HIV-geïnfecteerde</span> kinderen</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'>CDC</p>
| + | |
| - | |- style='mso-yfti-irow:81' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.2.%20Vaccinatie%20tegen%20influenza">17.2.
| + | |
| - | Vaccinatie tegen influenza</a></p> | + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>NHG Standaard</p>
| + | |
| - | |- style='mso-yfti-irow:82' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20influenza">Onderbouwing
| + | |
| - | Vaccinatie tegen influenza</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:83'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.2">Literatuur
| + | |
| - | 17.2</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:84' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.3.%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29">17.3.
| + | |
| - | Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:85'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29%20%28Pneumokokken%29">Onderbouwing
| + | |
| - | Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)
| + | |
| - | (Pneumokokken)</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:86'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.3">Literatuur
| + | |
| - | 17.3</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:87'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.4.%20Vaccinaties%20tegen%20Hepatitis%20A%20en%20B">17.4.
| + | |
| - | Vaccinaties tegen Hepatitis A en B</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:88' | + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.5.%20Vaccinatie%20bij%20HIV-ge%C3%AFnfecteerde%20reizigers">17.5.
| + | |
| - | Vaccinatie bij <span class=SpellE>HIV-geïnfecteerde</span><span
| + | |
| - | class=SpellE>reizigers</span></a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'>LCR</p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'>CDC</p>
| + | |
| - | |- style='mso-yfti-irow:89'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bureau%27s%20voor%20reizigersadvisering"><span
| + | |
| - | class=SpellE>Bureau's</span> voor reizigersadvisering</a></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><o:p> </o:p></p>
| + | |
| - | |- style='mso-yfti-irow:90'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><b><o:p> </o:p></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |- style='mso-yfti-irow:91;mso-yfti-lastrow:yes'
| + | |
| - | | width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | + | |
| - | normal'><b><a
| + | |
| - | href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2018.%20Kostenoverzicht%20antiretrovirale%20middelen">Hoofdstuk
| + | |
| - | 18. Kostenoverzicht antiretrovirale middelen</a></b></p>
| + | |
| - | | width=269 valign=top style='width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
| + | |
| - | normal'><span style='mso-bidi-font-weight:bold'><o:p> </o:p></span></p>
| + | |
| - | |}<p class=MsoNormal><o:p> </o:p></p></div></body></html> | + | |
In onderstaande tabel staan per hoofdstuk/paragraaf verwijzingen naar andere richtlijnen vermeld:
